Improved outcome of hematopoietic SCT in patients with homozygous gene variant of Toll-like receptor 9ELMAAGACLI, A. H; KOLDEHOFF, M; BEELEN, D. W et al.Bone marrow transplantation (Basingstoke). 2009, Vol 44, Num 5, pp 295-302, issn 0268-3369, 8 p.Article

Human herpesvirus 6 is an important pathogen in infectious lung disease after allogeneic bone marrow transplantationBUCHBINDER, S; ELMAAGACLI, A. H; SCHAEFER, U. W et al.Bone marrow transplantation (Basingstoke). 2000, Vol 26, Num 6, pp 639-644, issn 0268-3369Article

Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantationELMAAGACLI, A. H; KOLDEHOFF, M; LANDT, O et al.Bone marrow transplantation (Basingstoke). 2008, Vol 41, Num 9, pp 821-826, issn 0268-3369, 6 p.Article

A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantationELMAAGACLI, A. H; BEELEN, D. W; SCHAEFER, U. W et al.Bone marrow transplantation (Basingstoke). 1997, Vol 20, Num 12, pp 1045-1055, issn 0268-3369Article

Caspofungin as second-line therapy for fever of unknown origin or invasive fungal infection following allogeneic stem cell transplantationTRENSCHEL, R; DITSCHKOWSKI, M; BEELEN, D. W et al.Bone marrow transplantation (Basingstoke). 2005, Vol 35, Num 6, pp 583-586, issn 0268-3369, 4 p.Article

Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemiaKOLDEHOFF, M; BEELEN, D. W; TRENSCHEL, R et al.Bone marrow transplantation (Basingstoke). 2004, Vol 34, Num 12, pp 1047-1050, issn 0268-3369, 4 p.Article

Quality assurance in RT-PCR-based BCR/ABL diagnostics: results of an interlaboratory test and a standardization approachBURMEISTER, T; MAURER, J; LÜBBERT, M et al.Leukemia. 2000, Vol 14, Num 10, pp 1850-1856, issn 0887-6924Article

Bronchiolitis obliterans after allogeneic hematopoietic SCT: further insight—new perspectives?DITSCHKOWSKI, M; ELMAAGACLI, A. H; KOLDEHOFF, M et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 9, pp 1224-1229, issn 0268-3369, 6 p.Article

Myeloablative allogeneic hematopoietic stem cell transplantation in elderly patientsDITSCHKOWSKI, M; ELMAAGACLI, A. H; TRENSCHEL, R et al.Clinical transplantation. 2006, Vol 20, Num 1, pp 127-131, issn 0902-0063, 5 p.Article

A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phaseELMAAGACLI, A. H; RUNKEL, K; STECKEL, N et al.Bone marrow transplantation (Basingstoke). 2001, Vol 27, Num 8, pp 809-815, issn 0268-3369Article

The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stageELMAAGACLI, A. H; BEELEN, D. W; OPALKA, B et al.Annals of hematology (Print). 2000, Vol 79, Num 8, pp 424-431, issn 0939-5555Article

The detection of wt-1 transcripts is not associated with an increased leukemic relapse rate in patients with acute leukemia after allogeneic bone marrow or peripheral blood stem cell transplantationELMAAGACLI, A. H; BEELEN, D. W; TRENSCHEL, R et al.Bone marrow transplantation (Basingstoke). 2000, Vol 25, Num 1, pp 91-96, issn 0268-3369Article

Detection of minimal residual disease and persistence of host-type hematopoiesis : a study in 28 patients after sex-mismatched, non-T cell-depleted allogeneic bone marrow transplantation for Philadelphia-chromosome positive chronic myelogenous leukemiaELMAAGACLI, A. H; BECKS, H. W; BEELEN, D. W et al.Bone marrow transplantation (Basingstoke). 1995, Vol 16, Num 6, pp 823-829, issn 0268-3369Article

The risk of residual molecular and cytogenetic disease in patients with Philadelphia-chromosome positive first chronic phase chronic myelogenous leukemia is reduced after transplantation of allogeneic peripheral blood stem cells compared with bone marrow. IntroductionELMAAGACLI, A. H; BEELEN, D. W; OPALKA, B et al.Blood. 1999, Vol 94, Num 2, pp 381-389, issn 0006-4971Article

Molecular studies of chimerism and minimal residual disease after allogeneic peripheral blood progenitor cell or bone marrow transplantationELMAAGACLI, A. H; BEELEN, D. W; BECKS, H. W et al.Bone marrow transplantation (Basingstoke). 1996, Vol 18, Num 2, pp 397-403, issn 0268-3369Article

Human chorionic gonadotropin and indolamine 2,3-dioxygenase in patients with GVHDELMAAGACLI, A. H; DITSCHKOWSKI, M; STECKEL, N. K et al.Bone marrow transplantation (Basingstoke). 2014, Vol 49, Num 6, pp 800-805, issn 0268-3369, 6 p.Article

Toll-like receptor 9, NOD2 and IL23R gene polymorphisms influenced outcome in AML patients transplanted from HLA-identical sibling donorsELMAAGACLI, A. H; STECKEL, N; DITSCHKOWSKI, M et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 5, pp 702-708, issn 0268-3369, 7 p.Article

Outcome of allogeneic stem cell transplantation in patients with myelofibrosisDITSCHKOWSKI, M; BEELEN, D. W; TRENSCHEL, R et al.Bone marrow transplantation (Basingstoke). 2004, Vol 34, Num 9, pp 807-813, issn 0268-3369, 7 p.Article

Allogeneic CD34-enriched peripheral blood stem cell transplantation in a patient with paroxysmal nocturnal haemoglobinuriaDITSCHKOWSKI, M; TRENSCHEL, R; KUMMER, G et al.Bone marrow transplantation (Basingstoke). 2003, Vol 32, Num 6, pp 633-635, issn 0268-3369, 3 p.Article

Detection of CBFβ/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantationELMAAGACLI, A. H; BEELEN, D. W; KROLL, M et al.Bone marrow transplantation (Basingstoke). 1998, Vol 21, Num 2, pp 159-166, issn 0268-3369Article

Retrospective analysis of treosulfan-based conditioning in comparison with standard conditioning in patients with myelodysplastic syndromeHILGENDORF, I; WOLFF, D; GROMKE, T et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 4, pp 502-509, issn 0268-3369, 8 p.Article

Cytochrome P450 2C19 loss-of-function polymorphism is associated with an increased treatment-related mortality in patients undergoing allogeneic transplantationELMAAGACLI, A. H; KOLDEHOFF, M; STECKEL, N. K et al.Bone marrow transplantation (Basingstoke). 2007, Vol 40, Num 7, pp 659-664, issn 0268-3369, 6 p.Article

Impact of HLA-A, B, C allele mismatches on outcome after unrelated blood stem cell transplantation in whitesOTTINGER, H. D; FERENCIK, S; BEELEN, D. W et al.Transplantation. 2004, Vol 78, Num 7, pp 1077-1080, issn 0041-1337, 4 p.Article

Induction of a graft-versus-leukemia reaction by cyclosporin A withdrawal as immunotherapy for leukemia relapsing after allogeneic bone marrow transplantationELMAAGACLI, A. H; BEELEN, D. W; TRENN, G et al.Bone marrow transplantation (Basingstoke). 1999, Vol 23, Num 8, pp 771-777, issn 0268-3369Article

Prolonged administration of interferon-α in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcomeBEELEN, D. W; GRAEVEN, U; ELMAAGACLI, A. H et al.Blood. 1995, Vol 85, Num 10, pp 2981-2990, issn 0006-4971Article